Polymorphism of mucA and fpvA genes in Pseudomonas aeruginosa isolates from cystic fibrosis patients: Co-existence of genetically different variants;Polimorfismo de los genes mucA y fpvA en Pseudomonas aeruginosa de pacientes con fibrosis quística: coexistencia de variantes genéticas en el mismo paciente

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 29, Issue 1, 2011, Pages 26-31

  Pozuelo, María José ^a   Jiménez, Pedro A ^a   Valderrey, Andrea D ^b   Fernández Olmos, Ana ^c   Cantón, Rafael ^c   Rotger, Rafael ^b  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cystic fibrosis; fpvA; Genotyping; mucA; Pseudomonas aeruginosa; RFLP

Indexed keywords

ALGINIC ACID; BACTERIAL PROTEIN; FPVA PROTEIN; MUCA PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOSYNTHESIS; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE EXACERBATION; FOLLOW UP; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPAIN; STOP CODON;

ADOLESCENT; ADULT; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CHILD; CYSTIC FIBROSIS; FEMALE; GENETIC VARIATION; HUMANS; MALE; POLYMORPHISM, GENETIC; PSEUDOMONAS AERUGINOSA; YOUNG ADULT;

EID: 79952311265     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2010.05.006     Document Type: Article

References (34)

1. Saiman L. Microbiology of early CF lung disease. Paediatr Respir Rev. 2004;5:S367-9.
2. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Mol Biol Rev. 1996;60:539-74. (Pubitemid 26303478)
3. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15:194-222. (Pubitemid 34303763)
4. Deretic V, Schurr MJ, Yu H. Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis. Trends Microbiol. 1995;3:351-6.
5. Martin DW, Schurr MJ, Mudd MH, Govan JR, Holloway BW, Deretic V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A. 1993;90:8377-81. (Pubitemid 23277671)
6. Høiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros. 2005;4:49-54. (Pubitemid 41131329)
7. Anthony M, Rose B, Pegler MB, Elkins M, Service H, Thamotharampillai K, et al. Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of australian adult cystic fibrosis patients. J Clin Microbiol. 2002;40:2772-8. (Pubitemid 35284940)
8. Bennekov T, Colding H, Ojeniyi B, Bentzon MW, Hoiby N. Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol. 1996;34:202-4. (Pubitemid 126506925)
9. Syrmis MW, O'Carroll MR, Sloots TP, Coulter C, Wainwright CE, Bell SC, et al. Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays. J Med Microbiol. 2004;53:1089-96. (Pubitemid 40052490)
10. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA. 2006;103:8487-92. (Pubitemid 43838482)
11. Jelsbak L, Johansen HK, Frost AL, Thogersen R, Thomsen LE, Ciofu O, et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun. 2007;75:2214-24. (Pubitemid 46744308)
12. Aaron SD, Ramotar K, Ferris W, Vandemheen K, Saginur R, Tullis E, et al. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. Am J Respir Crit Care Med. 2004;169:811-5. (Pubitemid 38402456)
13. Margolis E, Yates A, Levin B. The ecology of nasal colonization of Streptococcus pneumoniae. Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host's immune response BMC Microbiology. 2010;10:59.
14. Ramsey DM,Wozniak DJ. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol Microbiol. 2005;56:309-22.
15. Spencer DH, Kas A, Smith EE, Raymond CK, Sims EH, Hastings M, et al. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol. 2003;185:1316-25. (Pubitemid 36176864)
16. Bragonzi A, Wiehlmann L, Klockgether J, Cramer N, Worlitzsch D, Doring G, et al. Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology. 2006;152:3261-9. (Pubitemid 44734330)
17. Oliver A, Canton R, Campo P, Baquero F, Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science. 2000;288:1251-4.
18. Boucher JC, Yu H, Mudd MH, Deretic V, Mucoid. Pseudomonas aeruginosa in cystic fibrosis: characterization of mucmutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun. 1997;65:3838-46.
19. Smith EE, Sims EH, Spencer DH, Kaul R, Olson MV. Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa. J Bacteriol. 2005;187:2138-47. (Pubitemid 40316244)
20. Wong K, Roberts MC, Owens L, Fife M, Smith AL. Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol. 1984;17:113-9. (Pubitemid 14161754)
21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsedfield gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
22. de Chial M, Ghysels B, Beatson SA, Geoffroy V, Meyer JM, Pattery T, et al. Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa. Microbiology. 2003;149:821-31. (Pubitemid 36553352)
23. Bodilis J, Ghysels B, Osayande J, Matthijs S, Pirnay J-P, Denayer J, et al. Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa. Environ Microbiol. 2009;11:2123-35.
24. Rosenfeld M, Ramsey BW, Gibson RL. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr Opin Pulm Med. 2003;9:492-7. (Pubitemid 37268213)
25. Moyano AJ, Smania AM. Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa. PLoS One. 2009;4:e8203.
26. Ciofu O, Lee B, Johannesson M, Hermansen NO, Meyer P, Hoiby N, et al. Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology. 2008;154:103-13. (Pubitemid 351201391)
27. Cezairliyan BO, Sauer RT. Control of Pseudomonas aeruginosa AlgW protease cleavage of MucA by peptide signals and MucB. Mol Microbiol. 2009;72:368-79.
28. Reiling SA, Jansen JA, Henley BJ, Singh S, Chattin C, ChandlerM,et al. Prc protease promotes mucoidy in mucA mutants of Pseudomonas aeruginosa.Microbiology. 2005;151:2251-61.
29. Qiu D, Eisinger VM, Rowen DW, Yu HD. Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 2007;104:8107-12. (Pubitemid 47185883)
30. Boucher JC, Martinez-Salazar J, Schurr MJ, Mudd MH, Yu H, Deretic V. Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA. J Bacteriol. 1996;178:511-23. (Pubitemid 26030607)
31. Martin DW, Schurr MJ, Mudd MH, Deretic V. Differentiation of Pseudomonas aeruginosa into the alginate-producing form: inactivation of mucB causes conversion to mucoidy. Mol Microbiol. 1993;9:497-506. (Pubitemid 23248762)
32. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, et al. Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 2007;104:8101-6. (Pubitemid 47185882)
33. Mossialos D, Amoutzias GD. Role of siderophores in cystic fibrosis pathogenesis: Foes or friends? Int J Med Microbiol. 2009;299:87-98.
34. Macia MD, Blanquer D, Togores B, Sauleda J, Perez JL, Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother. 2005;49:3382-6. (Pubitemid 41060586)